Muhammad Anwar-ul- Haq
The research of pharmaceutical domain has perceived a standard to transfer the emergence of nanotechnology and aiding the progress of innovative drug delivery systems that improve the therapeutic value to minimize the adverse effects. Nanotechnology is the advanced science, through these techniques the scientists developed various nanocarriers, which are used in the preparation of many types of drugs in the pharmaceutical industries in the recent years. Honey-made nanoparticles is pervasive substance and is reaped as a capacity of biocompatible and biodegradable in the field of medical industries. Natural honey is also played an integral role as an activity of antimicrobial and antioxidant substance in the drug delivery of medical science. In recent days, young researchers are busying to design the various types of nanocarriers from various parts of the plant body that are used as a therapeutic agent. Similarly, it is the potential of natural honey due to its unique and binding properties, it is widely used by the scientists in making the nanoparticles honey-based, which are not only enable the meticulous agents for therapy procedure of various human diseases and also it is a source for the targeted delivery of drugs to specific sites within the body. The human epidemic types diseases like cancer, transmittable ailments and neuro-degenerative disorders spread in the country very frequently, but their treatments are being done through these novel nanoparticle’s technique. These unique techniques are also dignified and defined a new source of revolution in the field of pharma-medical research. Moreover, as like the new types of disease and aliments are developing/emerging across the globe. It is the challenges for the scientific community related to medical fields and to cope such types of disease with new scientific approaches like nano-based technology rather than traditional drug delivery systems. Numerous drugs in the market have limited absorption properties like solubility, stability, and bioavailability in the body that could lead to reduced effectiveness and in other words increased side effects in the individuals. Furthermore, the current conventional drug delivery systems in developing countries like Pakistan often rely on a saying of “one-size-fits-all” approach, which can result in inadequate treatment outcomes for individual patients and it is very dangerous for the society. From centuries ago, -till today honey was/is used for medical purposes due to its inimitable properties like “phenolic compounds, flavonoids and antioxidant”, the status of honey viscous substance is a bio-compatible and bio-degradable in nature. So, it is used in the preparation of various drugs as an ideal and targeted component. There are numerous benefits of honey-based nanocarriers., which are assessed by experimental and practical bases in the field of medicines and minimizing the side effects in the human body is one of them. Honey-made nano carriers are providing a platform for the co-delivery of multiple therapeutic agents, enabling the treatment of complex diseases. Honey is also scalable and cost-effective substance, making them an attractive option for pharmaceutical companies and healthcare systems across the world. Finally, it is concluded that honey-based nanocarriers offer a promising solution to the challenges associated with traditional drug delivery systems, enabling the development of more effective, efficient, and personalized treatments.
The Author is M. Phil. Scholar in Zoology Department of Biological & Environmental Sciences Emersion University Multan
